Regulated Information
Financial Reports
06
May
2022
Celyad Oncology Announces First Quarter 2022 Financial Results and Recent Business Highlights
05
Aug
2022
Celyad Oncology Reports First Half 2022 Financial Results and Recent Business Highlights
SEC Filings
Filter
| Filing Date | Form | Description | Filing Group | Downloads |
|---|---|---|---|---|
| December 14, 2021 | 6-K | Celyad Oncology Presents Updates on shRNA-Based CAR T Programs at the 63rd ASH Annual Meeting and Exposition | ||
| December 8, 2021 | 6-K | Celyad Oncology Announces Closing of $32.5 Million Private Placement with Fortress Investment Group Affiliate | ||
| December 3, 2021 | 6-K | Celyad Oncology Announces $32.5 Million Private Placement With Fortress Investment Group | ||
| November 12, 2021 | 6-K | Celyad Oncology Presents Preclinical Data On Allogeneic CAR T Therapy Program And Highlights KEYNOTE-B79 Clinical Trial Design At The Society For Immunotherapy Of Cancer (SITC) 36th Annual Meeting | ||
| November 10, 2021 | 6-K | Celyad Oncology Announces Third Quarter 2021 Financial Results and Recent Business Highlights | ||
| August 4, 2021 | 6-K | Celyad Oncology Reports First Half 2021 Financial Results And Recent Business Highlights |
Regulated Information
Filter
Request for proposal of external statutory Auditor mandate
Interim Financial Report – First Half 2022
RAPPORT FINANCIER INTERMEDIAIRE
